Literature DB >> 19414577

Reduction of amphotericin B-induced renal tubular apoptosis by N-acetylcysteine.

Z Odabasi1, A Karaalp, H Cermik, J Mohr, E T Tigen, M Koc, V Korten.   

Abstract

The reduction of amphotericin B (AmB)-induced renal tubular apoptosis and nephrotoxicity by N-acetylcysteine (NAC) in a murine model was evaluated. Four groups of rats were treated with AmB for 5 days, and each group concomitantly received two doses of 30, 60, or 120 mg of NAC/kg of body weight/day or sterile water for 5 days. Groups that received concomitant NAC at any dose had significantly decreased levels of apoptosis compared to that in animals receiving AmB only (48.8% versus 27.4, 23.6, or 23.5%, respectively; P < 0.001).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19414577      PMCID: PMC2704667          DOI: 10.1128/AAC.00001-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

1.  Comparison of nephrotoxicity of amphotericin B products.

Authors:  C Carrigan Harrell; L Hanf-Kristufek
Journal:  Clin Infect Dis       Date:  2001-03-15       Impact factor: 9.079

2.  Mortality and costs of acute renal failure associated with amphotericin B therapy.

Authors:  D W Bates; L Su; D T Yu; G M Chertow; D L Seger; D R Gomes; E J Dasbach; R Platt
Journal:  Clin Infect Dis       Date:  2001-02-21       Impact factor: 9.079

3.  Nephrotoxicity of amphotericin B desoxycholate.

Authors:  C Girmenia; G Gentile; A Micozzi; P Martino
Journal:  Clin Infect Dis       Date:  2001-09-15       Impact factor: 9.079

Review 4.  Amphotericin B-induced nephrotoxicity: a review.

Authors:  V Fanos; L Cataldi
Journal:  J Chemother       Date:  2000-12       Impact factor: 1.714

5.  Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial.

Authors:  U Eriksson; B Seifert; A Schaffner
Journal:  BMJ       Date:  2001-03-10

6.  Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis.

Authors:  J R Wingard; P Kubilis; L Lee; G Yee; M White; L Walshe; R Bowden; E Anaissie; J Hiemenz; J Lister
Journal:  Clin Infect Dis       Date:  1999-12       Impact factor: 9.079

7.  Apoptosis contributes to amphotericin B-induced nephrotoxicity.

Authors:  D E Varlam; M M Siddiq; L A Parton; H Rüssmann
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

8.  The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy.

Authors:  S Harbarth; S L Pestotnik; J F Lloyd; J P Burke; M H Samore
Journal:  Am J Med       Date:  2001-11       Impact factor: 4.965

9.  Acetylcysteine and contrast agent-associated nephrotoxicity.

Authors:  Carlo Briguori; Fiore Manganelli; Pierfranco Scarpato; Pietro Paolo Elia; Bruno Golia; Guido Riviezzo; Stefano Lepore; Mariateresa Librera; Bruno Villari; Antonio Colombo; Bruno Ricciardelli
Journal:  J Am Coll Cardiol       Date:  2002-07-17       Impact factor: 24.094

Review 10.  N-acetylcysteine in the prevention of contrast-induced nephropathy.

Authors:  Steven Fishbane
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-14       Impact factor: 8.237

View more
  7 in total

1.  N-acetyl cysteine in prevention of amphotericin- induced electrolytes imbalances: a randomized, double-blinded, placebo-controlled, clinical trial.

Authors:  Iman Karimzadeh; Hossein Khalili; Simin Dashti-Khavidaki; Ramezanali Sharifian; Alireza Abdollahi; Mehrdad Hasibi; Zahra Khazaeipour; Shadi Farsaei
Journal:  Eur J Clin Pharmacol       Date:  2014-01-21       Impact factor: 2.953

2.  Multiparameter screening reveals a role for Na+ channels in cytokine-induced β-cell death.

Authors:  Yu Hsuan Carol Yang; Yury Y Vilin; Michel Roberge; Harley T Kurata; James D Johnson
Journal:  Mol Endocrinol       Date:  2014-01-17

Review 3.  N-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: from preclinical data to clinical evidence.

Authors:  Hesamoddin Hosseinjani; Azadeh Moghaddas; Hossein Khalili
Journal:  Eur J Clin Pharmacol       Date:  2013-03-19       Impact factor: 2.953

Review 4.  Role of diuretics and lipid formulations in the prevention of amphotericin B-induced nephrotoxicity.

Authors:  Iman Karimzadeh; Hossein Khalili; Shadi Farsaei; Simin Dashti-Khavidaki; Mohammad Mahdi Sagheb
Journal:  Eur J Clin Pharmacol       Date:  2013-01-30       Impact factor: 2.953

5.  Sinonasal mucormycosis and liposomal amphotericin B: A quest for dose optimization.

Authors:  Smile Kajal; Syed Shariq Naeem; Pooja Gupta; Arvind Kumar Kairo; Anam Ahmed; Prankur Verma; Ashish Saini
Journal:  Indian J Pharmacol       Date:  2022 Mar-Apr       Impact factor: 2.833

6.  Caffeic acid phenethyl ester protects against amphotericin B induced nephrotoxicity in rat model.

Authors:  Atila Altuntaş; H Ramazan Yılmaz; Ayşegül Altuntaş; Efkan Uz; Murat Demir; Alparslan Gökçimen; Oğuzhan Aksu; Dilek Şenol Bayram; Mehmet Tuğrul Sezer
Journal:  Biomed Res Int       Date:  2014-06-16       Impact factor: 3.411

7.  N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions.

Authors:  Bahadir Ceylan; Mehmet Ozansoy; Ülkan Kılıç; Yasemin Yozgat; Çilem Ercan; Pelin Yıldız; Turan Aslan
Journal:  Ren Fail       Date:  2018-11       Impact factor: 2.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.